Table 1.
Participation in the study
| GPP participation in 2016–2017 | QoF | NDA | NDA >100 T2DM patients | GPP also participating in 2015–2016 |
| Number of practices | 7366 | 6873 | 6614 | 5488 |
| Population | 57 925 672 | 54 953 783 | 53 837 296 | 45 588 943 |
| DM register | 3 112 478 | 2 958 290 | 2 927 864 | 2 471 551 |
| NDA T2 | 2 699 945 | 2 683 420 | 2 267 835 | |
| NDA T2 HbA1c % ≤58 | 66.9% | 66.9% | 66.8% | |
| NDA T2 HbA1c % >86 | 6.7% | 6.7% | 6.7% |
GPP, general practitioner practice; NDA, National Diabetes Audit; QoF, Quality and Outcome Framework.